News & Press Release : 2016 | Nobelpharma Co., Ltd.

2016-11-30 Announcements Announcing a Comprehensive Business Tie-up between Nobelpharma and ASKA Pharmaceutical in the Field of Obstetrics and Gynecology

2016-11-01 Product Information Marketing authorization for Foscavir®, antiviral chemothrapeutic agent, transferred to Clinigen KK

2016-09-08 Product Information Titanium bridge (NPC-17) received orphan designation from MHLW

2016-08-01 Announcements Received Lisence for Marketing Class 1 Medical Devices

2016-07-04 Product Information NPC-04 (oxcarbazepine) Approved by PMDA for the Treatment of Partial Epilepsy

2016-05-31 Announcements Nobelpharma signs license agreement with Danish Serendex Pharmaceuticals A/S for future commercialization of Molgradex®(inhaled GM-CSF therapy) for Pulmonary Alveolar Proteinosis in Japan

2016-02-24 Announcements Medical Device “Titanium Bridge” (for type II thyroplasty) Gets Sakigake Designation from the Ministry of Health, Labor and Welfare for Fast-track Review

2016-01-06 Announcements President Jin Shiomura featured in January 2016 winter issue of “HQ,” the Hitotsubashi University magazine

2016-01-03 Announcements An article on our sirolimus (NPC-12G) with the designation under SAKIGAKE Review System published on Nihon Keizai Shimbun